Glucose-regulated stresses induce resistance to camptothecin in human cancer cells

International Journal of Cancer

Volumn 68, Issue 3, 1996, Pages 391-396

  Tomida, Akihiro ^a   Yun, Jisoo ^a   Tsuruo, Takashi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; FLUOROURACIL; GLUCOSE REGULATED PROTEIN; VINCRISTINE;

ARTICLE; CELL CYCLE; COLON CARCINOMA; CONTROLLED STUDY; DRUG RESISTANCE; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; STRESS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, ALKYLATING; CAMPTOTHECIN; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, NEOPLASM; FEMALE; GLUCOSE; HSP70 HEAT-SHOCK PROTEINS; HT29 CELLS; HUMANS; MEMBRANE PROTEINS; OVARIAN NEOPLASMS; STRESS; TUMOR CELLS, CULTURED;

EID: 0029835447     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961104)68:3<391::AID-IJC19>3.0.CO;2-B     Document Type: Article

References (27)

1. ANDOH, T., ISHII, K., SUZUKI, Y., IKEGAMI, Y., KUSUNOKI, Y., TAKEMOTO, Y. and OKADA, K., Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I. Proc. nat. Acad. Sci. (Wash.), 84, 5565-5569 (1987).
2. BROWN, R., CLUGSTON, C., BURNS, P., EDLIN, A., VASEY, P., VOJTESEK, B. and KAYE, S.B., Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. Int. J. Cancer, 55, 678-684 (1993).
3. CAI, J.W., HENDERSON, B.W., SHEN, J.W. and SUBJECK, J.R., Induction of glucose regulated proteins during growth of a murine tumor. J. cell. Physiol., 154, 229-237 (1993).
4. CHANG, J.Y., DETHLEFSEN, L.A., BARLEY, L.R., ZHOU, B.S. and CHENG, Y.C., Characterization of camptothecin-resistant Chinese hamster lung cells. Biochem. Pharmacol., 43, 2443-2452 (1992).
5. CHEN, A.Y. and LIU, L.F., DNA topoisomerases: essential enzymes and lethal targets. Ann. Rev. Pharmacol. Toxicol., 34, 191-218 (1994).
6. GOLDWASSER, F., BAE, I., VALENTI, M., TORRES, K. and POMMIER, Y., Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute anticancer screen. Cancer Res., 55, 2116-2121 (1995).
7. 1phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. cell. Biol., 14, 6264-6277 (1994).
8. GUPTA, R.S., GUPTA, R., ENG, B., LOCK, R.B., ROSS, W.E., HERTZBERG, R.P., CARANFA, M.J. and JOHNSON, R.K., Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I. Cancer Res., 48, 6404-6410 (1988).
9. HARTWELL, L.H. and KASTAN, M.B., Cell cycle control and cancer. Science, 266, 1821-1828 (1994).
10. HSIANG, Y.H. and LIU, L.F., Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res., 48, 1722-1726 (1988).
11. HUGHES, C.S., SHEN, J.W. and SUBJECK, J.R., Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells. Cancer Res., 49, 4452-4454 (1989).
12. KANAZAWA, F., SUGIMOTO, Y., MINATO, K., KASAHARA, K., BUNGO, M., NAKAGAWA, K., FUJIWARA, Y., LIU, L.F. and SAIJO, N., Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: characterization and mechanism of resistance. Cancer Res., 50, 5919-5924 (1990).
13. LEE, A.S., The accumulation of three specific proteins related to glucose-regulated proteins in a temperature-sensitive hamster mutant cell line K12. J. cell. Physiol., 106, 119-125 (1981).
14. LEE, A.S., Coordinated regulation of a set of genes by glucose and calcium ionophores in mammalian cells. Trends Biochem. Sci., 12, 20-23 (1987).
15. LIU, L.F., DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem., 58, 351-375 (1989).
16. POMMIER, Y., LETEURTRE, F., FESEN, M.R., FUJIMORI, A., BERTRAND, R., SOLARY, E., KOHLHAGEN, G. and KOHN, K.W., Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest., 12, 530-542 (1994).
17. RODRIGUES, N.R., ROWAN, A., SMITH, M.E., KERR, I.B., BOOMER, W.F., GANNON, J.V. and LANE, D.P., p53 mutations in colorectal cancer. Proc. nat. Acad. Sci. (Wash.), 87, 7555-7559 (1990).
18. SHEN, J., HUGHES, C., CHAO, C., CAI, J., BARTELS, C., GESSNER, T. and SUBJECK, J., Conduction of glucose-regulated proteins and doxorubicin resistance in Chinese hamster cells. Proc. nat. Acad. Sci. (Wash.), 84, 3278-3282 (1987).
19. SHEN, J.W., SUBJECK, J.R., LOCK, R.B. and ROSS, W.E., Depletion of topoisomerase II in isolated nuclei during a glucose-regulated stress response. Mol. cell. Biol., 9, 3284-3291 (1989).
20. SLICHENMYER, W.J., ROWINSKY, E.K., DONEHOWER, R.C. and KAUFMANN, S.H., The current status of camptothecin analogues as antitumor agents. J. nat. Cancer Inst., 85, 271-291 (1993).
21. SUGIMOTO, Y., TSUKAHARA, S., OH-HARA, T., ISOE, T. and TSURUO, T., Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody. Cancer Res., 50, 6925-6930 (1990).
22. SUTHERLAND, R.M., Cell and environment interactions in tumor microregions: the multicell spheroid model. Science, 240, 177-184 (1988).
23. TAKEDA, S., SHIMAZOE, T., SATO, K., SUGIMOTO, Y., TSURUO, T. and KONO, A., Differential expression of DNA topoisomerase I gene between CPT-11 acquired- and native-resistant human pancreatic tumor cell lines: detected by RNA/PCR-based quantitation assay. Biochem. biophys. Res. Comm., 184, 618-625 (1992).
24. TANIZAWA, A., FUJIMORI, A., FUJIMORI, Y. and POMMIER, Y., Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials. J. nat. Cancer Inst., 86, 836-842 (1994).
25. TATSUTA, T., NAITO, M., OH-HARA, T., SUGAWARA, I. and TSURUO, T., Functional involvement of P-glycoprotein in blood-brain barrier. J. biol. Chem., 267, 20383-20391 (1992).
26. TOMIDA, A., NAITO, M. and TSURUO, T., Acute induction of adriamycin-resistance in human colon carcinoma HT-29 cells exposed to a sublethal dose of adriamycin. Jpn. J. Cancer Res., 86, 224-232 (1995).
27. YUN, J., TOMIDA, A., NAGATA, K. and TSURUO, T., Glucose-regulated stresses confer resistance to VP-16 in human cancer cells through a decreased expression of DNA topoisomerase II. Oncol. Res., 7, 583-590 (1995).